Research
Cure SMA Announces Additional $315,000 for SMA Drug Program at The California Institute of Biomedical Research
Cure SMA is pleased to announce that we have extended our spinal muscular atrophy research program with the California Institute of Biomedical Research (CALIBR) with […]
Read More ›Cure SMA Releases Updated Overview of Research Model
When Cure SMA first started funding research thirty years ago, we had to build up from virtually nothing. It’s no easy task. Drug development relies […]
Read More ›Cure SMA Hosts SMA Researcher Meeting this June
The Annual SMA Conference consists of two separate events that run in parallel. The first is focused on families affected by SMA, who gather for […]
Read More ›Cure SMA Awards $140,000 Grant to Francesco Lotti, PhD, of Columbia University
Cure SMA has awarded a $140,000 research grant to Francesco Lotti, PhD, at Columbia University, for his project, “Role of Sumoylation in SMN Function and […]
Read More ›Cure SMA-Funded Researcher Publishes Paper on Critical Issues for SMA Families and Doctors
Matthew A. Halanski, a Cure SMA-funded researcher from University of Wisconsin – Madison, was the lead author on, “Assessing the Needs of the SMA Population,” […]
Read More ›Roche Buys Trophos to Continue Work on SMA Drug
Swiss drugmaker Roche has agreed to buy privately-held Trophos. Roche, the third largest pharmaceutical company in the world, will now bring its resources to help […]
Read More ›Cure SMA Announces New $30,000 Clinical Care Research Grant to Deborah Boroughs at BAYADA Home Health Care
Cure SMA has awarded a $30,000 clinical care grant to Deborah Boroughs, RN, MSN, for her project focusing on caregiver training. Individuals with SMA have […]
Read More ›Cure SMA Awards $140,000 Grant to Sara Custer, PhD, of Indiana University
Audrey Lewis founded Families of SMA, now Cure SMA, 30 years ago. Audrey recognized early on the importance of attracting new and talented researchers to […]
Read More ›Cure SMA Announces New $50,000 Care Research Grant to Rebecca Davis in the Lab of Dr. Swoboda at University of Utah
Cure SMA has awarded a $50,000 clinical care grant to Rebecca Hurst Davis in the lab of Dr. Kathy Swoboda, for her project focusing on […]
Read More ›Cytokinetics and Astellas Announce New Phase 2 Clinical Trial
Cytokinetics and Astellas jointly announced plans to begin a Phase 2 clinical trial in 2015 in patients with spinal muscular atrophy. The trial will test […]
Read More ›